Abiopharma

Performance Shipping Inc. Announces Approval of Amendments Making Its Bonds Senior Unsecured

SUNTEX ENTERPRISES APPOINTS FORMER SPACEX EXECUTIVE TECHNOLOGY SPECIALIST VINCENT ORNELAS TO BOARD OF DIRECTORS

Bonus Issue/ Capitalisation Issue :

Clinical trial NCT05629624 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-08-01 → 2025-01-31 3. primary completion date: 2024-08-01 → 2025-01-31 4. enrollment: 280 → 297 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05377996 updates: 1. completion date: 2027-05-01 → 2027-12-01 2. primary completion date: 2026-12-01 → 2027-02-01 3. enrollment: 319 → 360 participants

Clinical trial NCT06627647 updates: 1. completion date: 2030-03-25 → 2030-11-18 2. primary completion date: 2029-05-10 → 2030-11-18

Clinical trial NCT03919292: status: RECRUITING → SUSPENDED.

Clinical trial NCT06970743 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 150 → 153 participants

Clinical trial NCT05721404 updates: 1. completion date: 2025-12-31 → 2027-12-31 2. primary completion date: 2025-04-28 → 2027-04-28

Clinical trial NCT06851559 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-03-01 → 2027-01-01 3. primary completion date: 2026-12-01 → 2026-10-01 4. enrollment: 80 → 95 participants 5. enrollment type: ESTIMATED → ACTUAL